Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
David Riddell(Eli Lilly (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Jan Jacobsen(Princeton University), Zhuting Li(Princeton University), A. Parratt(Princeton University), Hua Zhou(Dalian Medical University), Erik Wagner(Princeton University), Julius J. Jefferson(Princeton University), Peter J. Atkinson(Princeton University), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lin Xu(Harbin Medical University), Yolanda Kirksey(Princeton University), Helen K. Warwick(Princeton University), Suzan Aschmies(Princeton University), Margaret M. Zaleska, Jane Xu(Princeton University), Yun Hu(Princeton University)
Cited by 351
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Proteogenomic Characterization of Endometrial Carcinoma
|Cell|2020|534
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302